Literature DB >> 14510990

The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester.

G A Johnston1, R M Bilbao, R A C Graham-Brown.   

Abstract

BACKGROUND: The use of 'complementary' or 'alternative' medicine continues to rise in patients with skin disease, especially in those with chronic, inflammatory dermatoses.
OBJECTIVES: To qualify and quantify the usage of complementary medicine (CM) in children with atopic dermatitis (AD) in secondary care.
METHODS: A face-to-face structured questionnaire study of 100 consecutive children with AD and their parent or guardian.
RESULTS: The mean age of the children interviewed was 7.3 years (median age 6.0 years, range 0.6-17.1) and ethnic origin was 59% white, 35% Indian, 3% Afro-Caribbean and 3% mixed race. Forty-six of 100 patients (46%) had used, or were currently using, CM. Of the 54 patients who had not yet used CM, 17 of 54 (31%) said they intended to try this in the future. The most commonly used CM was Chinese herbal medicine by 20 of 46 patients (43% of those who had used CM), followed by herbal medicine (41%) and homeopathy (35%). Of 74 patients using CM, 26 (35%) felt their AD had improved while 39 of 74 (53%) reported that it had remained unchanged. Twenty-six of 46 (56%) CM users in this study would not recommend CM to other patients with AD. There was a strong association between the use of CM and ethnicity (P = 0.01). Half of the patients who had used CM (23 of 46) had used it on the recommendation of family or friends with skin disease, 17 of 46 (37%) from family or friends without skin disease and three of 46 (6%) each from health professionals or from the media or internet. Twenty-five of 46 (54%) of CM users did so because conventional treatment was not working, and eight of 46 (17%) because they were worried about the side-effects of conventional treatment. While 39 of 100 (39%) of all patients felt that CM was safer than conventional medicine, only 14 of 100 felt it was more efficacious. Fifty-one of 100 were happy to combine both types of treatment and 66 of 100 felt that CM should be available from the National Health Service.
CONCLUSIONS: In a population of children with AD attending a teaching hospital clinic in Leicester, U.K., 63% use or intend to use CM. This use is associated with ethnicity.

Entities:  

Mesh:

Year:  2003        PMID: 14510990     DOI: 10.1046/j.1365-2133.2003.05471.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  The effect of TJ-15 plus TJ-17 on atopic dermatitis: a pilot study based on the principle of pattern identification.

Authors:  In-Hwa Choi; Sehyun Kim; YoungChul Kim; Younghee Yun
Journal:  J Altern Complement Med       Date:  2012-06       Impact factor: 2.579

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-03       Impact factor: 2.253

3.  Homeopathy in the paediatric population.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-03       Impact factor: 2.253

4.  Chiropractic approach to the management of children.

Authors:  Sharon A Vallone; Joyce Miller; Annica Larsdotter; Jennifer Barham-Floreani
Journal:  Chiropr Osteopat       Date:  2010-06-02

Review 5.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

Review 6.  Experimental Drugs with the Potential to Treat Atopic Eczema.

Authors:  Kam Lun Ellis Hon; Vivian P Y Chan; Alexander K C Leung
Journal:  J Exp Pharmacol       Date:  2021-05-12

7.  Chinese herbal medicine research in eczema treatment.

Authors:  Kam Lun Hon; Ben Chung-Lap Chan; Ping Chung Leung
Journal:  Chin Med       Date:  2011-04-28       Impact factor: 5.455

8.  A practical approach to vitamin and mineral supplementation in food allergic children.

Authors:  Rosan Meyer; Claire De Koker; Robert Dziubak; Ana-Kristina Skrapac; Heather Godwin; Kate Reeve; Adriana Chebar-Lozinsky; Neil Shah
Journal:  Clin Transl Allergy       Date:  2015-03-10       Impact factor: 5.871

9.  Topical apigenin alleviates cutaneous inflammation in murine models.

Authors:  Mao-Qiang Man; Melanie Hupe; Richard Sun; George Man; Theodora M Mauro; Peter M Elias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-19       Impact factor: 2.629

10.  Factors and common conditions associated with adolescent dietary supplement use: an analysis of the National Health and Nutrition Examination Survey (NHANES).

Authors:  Paula Gardiner; Catherine Buettner; Roger B Davis; Russell S Phillips; Kathi J Kemper
Journal:  BMC Complement Altern Med       Date:  2008-03-31       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.